{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:20:05Z","timestamp":1790562005348,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry","award":["NO: [2015]311"],"award-info":[{"award-number":["NO: [2015]311"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11136-018-1819-2","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T18:57:41Z","timestamp":1519844261000},"page":"1323-1333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China"],"prefix":"10.1007","volume":"27","author":[{"given":"Liu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-6220","authenticated-orcid":false,"given":"Shunping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"issue":"2","key":"1819_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi, R., Symmons, D. P., Griffiths, C. E., & Ashcroft, D. M., (2013). Global epidemiology of psoriasis: A systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133(2), 377\u2013385.","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"1819_CR2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1684\/ejd.2012.1802","volume":"22","author":"X Ding","year":"2012","unstructured":"Ding, X., Wang, T., Shen, Y., Wang, X., Zhou, C., Tian, S., et al. (2012). Prevalence of psoriasis in China: A population-based study in six cities. European Journal of Dermatology, 22(5), 663\u2013667.","journal-title":"European Journal of Dermatology"},{"issue":"2","key":"1819_CR3","first-page":"59","volume":"2","author":"CG Shao","year":"1987","unstructured":"Shao, C. G., Zhang, G. W., & Wang, G. C. (1987). Distribution of psoriasis in China: A nationwide screening. Proceedings of the Chinese Academy of Medical Sciences Peking Union Medical College, 2(2), 59\u201365.","journal-title":"Proceedings of the Chinese Academy of Medical Sciences Peking Union Medical College"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/DDDT.S32713","volume":"7","author":"AC Palfreeman","year":"2013","unstructured":"Palfreeman, A. C., McNamee, K. E., & McCann, F. E. (2013). New developments in the management of psoriasis and psoriatic arthritis: A focus on apremilast. Drug Design, Development and Therapy, 7, 201\u2013210.","journal-title":"Drug Design, Development and Therapy"},{"key":"1819_CR5","volume-title":"Psoriasis - types, causes and medication (Chap. 07)","author":"D Colombo","year":"2013","unstructured":"Colombo, D., & Perego, R. (2013). Quality of life in psoriasis. In H. Lima (Ed.), Psoriasis: types, causes and medication (Chap. 07). Rijeka: InTech."},{"key":"1819_CR6","unstructured":"WHO (2016). Global Report on Psoriasis, http:\/\/apps.who.int\/iris\/bitstream\/10665\/204417\/1\/9789241565189_eng.pdf . Accessed March 21 2017."},{"key":"1819_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198725923.001.0001","volume-title":"Measuring and valuing health benefits for economic evaluation","author":"J Brazier","year":"2016","unstructured":"Brazier, J., Ratcliffe, J., Salomon, J., & Tsuchiya, A. (2016). Measuring and valuing health benefits for economic evaluation (2nd\u00a0edn). Oxford: Oxford University Press.","edition":"2"},{"issue":"1","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","volume":"5","author":"GW Torrance","year":"1986","unstructured":"Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1\u201330.","journal-title":"Journal of Health Economics"},{"key":"1819_CR9","volume-title":"Theory of games and economic behavior","author":"J Neumann von","year":"1944","unstructured":"von Neumann, J., & Morgenstern, O. (1944). Theory of games and economic behavior. Princeton: Princeton University Press."},{"issue":"2","key":"1819_CR10","first-page":"118","volume":"7","author":"GW Torrance","year":"1972","unstructured":"Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs. Health Services Research, 7(2), 118\u2013133.","journal-title":"Health Services Research"},{"issue":"Suppl 1","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1007\/s10198-013-0508-x","volume":"14","author":"AE Attema","year":"2013","unstructured":"Attema, A. E., Edelaar-Peeters, Y., Versteegh, M. M., & Stolk, E. A. (2013). Time trade-off: One methodology, different methods. European Journal of Health Economics, 14(Suppl 1), S53\u2013S64.","journal-title":"European Journal of Health Economics"},{"key":"1819_CR12","volume-title":"Applied methods of cost-effectiveness analysis in healthcare","author":"AM Gray","year":"2010","unstructured":"Gray, A. M., Clarke, P. M., Wolstenholme, J. L., & Wordsworth, S. (2010). Applied methods of cost-effectiveness analysis in healthcare. New York: Oxford University Press."},{"issue":"1","key":"1819_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53\u201372.","journal-title":"Health Policy"},{"key":"1819_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/B978-0-12-375678-7.00505-8","volume":"2","author":"J Richardson","year":"2014","unstructured":"Richardson, J., Mckie, J., & Bariola, E. (2014). Multiattribute utility instruments and their use. Encyclopedia of Health Economics, 2, 341\u2013357.","journal-title":"Encyclopedia of Health Economics"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"b2688","DOI":"10.1136\/bmj.b2688","volume":"339","author":"D Arnold","year":"2009","unstructured":"Arnold, D., Girling, A., Stevens, A., & Lilford, R. (2009). Comparison of direct and indirect methods of estimating health state utilities for resource allocation: Review and empirical analysis. BMJ, 339, b2688.","journal-title":"BMJ"},{"issue":"4","key":"1819_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jval.2014.03.002","volume":"17","author":"P Cubi-Molla","year":"2014","unstructured":"Cubi-Molla, P., de Vries, J., & Devlin, N. (2014). A study of the relationship between health and subjective well-being in Parkinson\u2019s disease patients. Value in Health, 17(4), 372\u2013379.","journal-title":"Value in Health"},{"key":"1819_CR17","doi-asserted-by":"publisher","unstructured":"Chen, G., Ratcliffe, J., Kaambwa, B., Mccaffrey, N., & Richardson, J. (2017). Empirical comparison between capability and two health-related quality of life measures. Social Indicators Research, (1), 1\u201316, https:\/\/doi.org\/10.1007\/s11205-017-1788-9 .","DOI":"10.1007\/s11205-017-1788-9"},{"issue":"4","key":"1819_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11136-012-0200-0","volume":"22","author":"N Luo","year":"2013","unstructured":"Luo, N., Li, M., Liu, G. G., Lloyd, A., de Charro, F., & Herdman, M. (2013). Developing the Chinese version of the new 5-level EQ-5D descriptive system: The response scaling approach. Quality of Life Research, 22(4), 885\u2013890.","journal-title":"Quality of Life Research"},{"issue":"10","key":"1819_CR19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727\u20131736.","journal-title":"Quality of Life Research"},{"issue":"4","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo, N., Liu, G., Li, M., Guan, H., Jin, X., & Rand-Hendriksen, K. (2017). Estimating an EQ-5D-5L value set for China. Value in Health, 20(4), 662\u2013669.","journal-title":"Value in Health"},{"issue":"3","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp, C. W., Ostergaard, S. D., Sondergaard, S., & Bech, P. (2015). The WHO-5 Well-Being Index: A systematic review of the literature. Psychotherapy and Psychosomatics, 84(3), 167\u2013176.","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"4","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000289073","volume":"65","author":"P Bech","year":"1996","unstructured":"Bech, P., Gudex, C., & Johansen, K. S. (1996). The WHO (Ten) well-being index: Validation in diabetes. Psychotherapy & Psychosomatics, 65(4), 183\u2013190.","journal-title":"Psychotherapy & Psychosomatics"},{"issue":"1","key":"1819_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2230.1987.tb01844.x","volume":"12","author":"AY Finlay","year":"1987","unstructured":"Finlay, A. Y., & Kelly, S. E. (1987). Psoriasis: An index of disability. Clinical & Experimental Dermatology, 12(1), 8\u201311.","journal-title":"Clinical & Experimental Dermatology"},{"issue":"2","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","volume":"132","author":"AY Finlay","year":"1995","unstructured":"Finlay, A. Y., & Coles, E. C. (1995). The effect of severe psoriasis on the quality of life of 369 patients. British Journal of Dermatology, 132(2), 236\u2013244.","journal-title":"British Journal of Dermatology"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1477-7525-10-37","volume":"10","author":"Z He","year":"2012","unstructured":"He, Z., Lu, C., Ou, A., Fang, J., Wang, D., Deng, J., et al. (2012). Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis. Health & Quality of Life Outcomes, 10, 37.","journal-title":"Health & Quality of Life Outcomes"},{"issue":"4","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis\u2013oral therapy with a new retinoid. Dermatologica, 157(4), 238\u2013244.","journal-title":"Dermatologica"},{"issue":"3","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000083509","volume":"210","author":"J Schmitt","year":"2005","unstructured":"Schmitt, J., & Wozel, G. (2005). The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology, 210(3), 194\u2013199.","journal-title":"Dermatology"},{"key":"1819_CR28","unstructured":"Fayers, P., & Machin, D. (2013). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes: Wiley."},{"issue":"8476","key":"1819_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1(8476), 307\u2013310.","journal-title":"Lancet"},{"issue":"1","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11205-015-1221-1","volume":"132","author":"Z Zhou","year":"2017","unstructured":"Zhou, Z., Fang, Y., Zhou, Z., Li, D., Wang, D., Li, Y., et al. (2017). Assessing income-related health inequality and horizontal inequity in China. Social Indicators Research, 132(1), 241\u2013256.","journal-title":"Social Indicators Research"},{"issue":"12","key":"1819_CR31","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s11136-017-1699-x","volume":"26","author":"AK Poor","year":"2017","unstructured":"Poor, A. K., Rencz, F., Brodszky, V., Gulacsi, L., Beretzky, Z., Hidvegi, B., et al. (2017). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Quality of Life Research, 26(12), 3409\u20133419.","journal-title":"Quality of Life Research"},{"issue":"5","key":"1819_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00403-017-1743-2","volume":"309","author":"J Yfantopoulos","year":"2017","unstructured":"Yfantopoulos, J., Chantzaras, A., & Kontodimas, S. (2017). Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Archives of Dermatological Research, 309(5), 357\u2013370.","journal-title":"Archives of Dermatological Research"},{"issue":"6","key":"1819_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1046\/j.1365-2133.1999.03207.x","volume":"141","author":"L Lundberg","year":"1999","unstructured":"Lundberg, L., Johannesson, M., Silverdahl, M., Hermansson, C., & Lindberg, M. (1999). Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. British Journal of Dermatology, 141(6), 1067\u20131075.","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"1819_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/14737167.2014.912562","volume":"14","author":"KS Boye","year":"2014","unstructured":"Boye, K. S., Matza, L. S., Feeny, D. H., Johnston, J. A., Bowman, L., & Jordan, J. B. (2014). Challenges to time trade-off utility assessment methods: When should you consider alternative approaches? Expert Review of Pharmacoeconomics & Outcomes Research, 14(3), 437\u2013450.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"8","key":"1819_CR35","first-page":"1","volume":"17","author":"LS Matza","year":"2015","unstructured":"Matza, L. S., Boye, K. S., Feeny, D. H., Bowman, L., Johnston, J. A., Stewart, K. D., et al. (2015). The time horizon matters: Results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation. European Journal of Health Economics Hepac Health Economics in Prevention & Care, 17(8), 1\u201312.","journal-title":"European Journal of Health Economics Hepac Health Economics in Prevention & Care"},{"issue":"1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2017","unstructured":"Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2017). Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Economics, 27(1), 7\u201322.","journal-title":"Health Economics"},{"issue":"7","key":"1819_CR37","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s11136-015-1212-3","volume":"25","author":"T Gamst-Klaussen","year":"2016","unstructured":"Gamst-Klaussen, T., Chen, G., Lamu, A. N., & Olsen, J. A. (2016). Health state utility instruments compared: Inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D. Quality of Life Research, 25(7), 1667\u20131678.","journal-title":"Quality of Life Research"},{"issue":"1","key":"1819_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12955-015-0297-2","volume":"13","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Tan, N. C., Tay, E. G., Thumboo, J., & Luo, N. (2015). Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore. Health & Quality of Life Outcomes, 13(1), 103.","journal-title":"Health & Quality of Life Outcomes"},{"issue":"8","key":"1819_CR39","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11136-014-0676-x","volume":"23","author":"S Clemens","year":"2014","unstructured":"Clemens, S., Begum, N., Harper, C., Whitty, J. A., & Scuffham, P. A. (2014). A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Quality of Life Research, 23(8), 2375\u20132381.","journal-title":"Quality of Life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-018-1819-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T21:13:13Z","timestamp":1603919593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-018-1819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1007\/s11136-018-1819-2","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"20 February 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Review Board of the School of Medicine, Shandong University (Reference No. LL-201401044), and the research adhered to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}